000520.KO Samil Pharm

Healthcare Pharmaceuticals Korea Stock Exchange
7,860 KRW
Close of Nov 4, 2026
5,500 12,860
Market cap
KRW 168B
P/E
-
P/B
1.28x
ROE
-29.5%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 000520.KO undervalued?

Graham number

The Graham number of Samil Pharm cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Samil Pharm fundamental analysis

No fundamental analysis for Samil Pharm yet.

Samil Pharm stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Samil Pharm

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of pharmaceuticals in South Korea. It offers general medicines, including Tiersil Once, EYE2O mini eye drops, and Optagent ophthalmic drops; medical devices; secret spotpatch quasi-drugs, and roll away products. The company also provides specialty medicines, such as Hycell solutions; Curelen, Ocufridine, Ocumetholone, Ocucyclo, Ocuhomapine, Ocucarpine, Allerfen, Optanac, Forus, Eymox, Cifex, and Ocuracin ophtha…

Full company profile